New Cell-Based Therapy Drives Progress Toward Diabetes Treatment, Prevention

Using new gene-editing techniques, Dr. David Rawlings and his lab team have created a novel cell therapy to potentially transform the treatment of autoimmune diseases.

Researchers Awarded Funding to Support Environmental Exposures Investigation in Washington

Researchers at the Center for Childhood Health, Behavior and Development awarded funding to support environmental exposures study in Washington.

Summer Scholars Program Provides Path to Science Careers

This summer, 49 college students assisted with 44 lab and clinical research projects involving 39 principal investigators.

Shaun Jackson Receives $3 Million Lupus Research Alliance Team Award

The pediatric rheumatologist and nephrologist will co-lead kidney imaging studies with a multidisciplinary team studying pediatric lupus nephritis.

Rare Disorder Research Yields Insights into Immune Dysregulation, Drug Approaches

Seattle Children’s researchers and colleagues have identified a new driver of autoimmunity that may be relevant to many diseases, including lupus.

Brainstem Region Revealed to Play Role in Regulating Swallow, Breathing

Seattle Children’s researchers revealed novel insights about PiCo, a brainstem region that aids the coordination of swallowing and breathing.

Airway Cells in Children With Allergic Asthma Protect Against COVID-19 Infection

Seattle Children’s researchers and colleagues discovered why kids with allergic asthma fare better against COVID-19.

Second Malaria Gene Linked to Drug Resistance

Seattle Children’s malaria researchers and colleagues found the putative amino acid transporter, pfaat1, contributes to chloroquine resistance.

Equity Initiatives Improve Healthcare-Associated Infections

May 30, 2023 – Rates of central line-associated bloodstream infections dropped after researchers identified disparities and initiated equity-focused measures.

Molly Taylor Awarded Funds to Study Stress Biomarkers

The oncologist and researcher received a five-year, $729,000 award from the American Cancer Society.

Finding an Allergy Brake

May 16, 2023 – Researchers in the Center for Immunity and Immunotherapies have discovered a new mechanism in human mast cells: They express an inhibitory receptor, Siglec-9, that can act as a brake on their activation.

Children’s Researchers Share Progress at ASGCT Annual Meeting

May 16, 2023 - Key findings from the Center for Immunity and Immunotherapies highlighted at the American Society of Gene and Cell Therapy’s Annual Meeting from May 16 to 20 in Los Angeles.

Tuberculosis Bacterium’s Cellular Signaling System Plays Key Role in its Biology

April 28, 2023 – Seattle Children’s TB researchers and colleagues uncovered complex microbial protein activity, potentially pointing to new drug targets.

James Bennett Receives $12.5 Million NIH Genome Research Grant Under SMaHT Network

May 11, 2023 – Congratulations to Dr. James Bennett for his $12.5 million, five-year National Institutes of Health award supporting research in how the human genome changes within individuals over their lifetimes.

Murdock Grant Enables New Cell Analyzer as Shared Resource

Apr. 24, 2023 - An M.J. Murdock Charitable Trust grant awarded to Drs. Rhea Coler and Shaun Jackson facilitates cell analyzer acquisition for the research institute’s Integrated Flow Cytometry Core.

Todd Cooper Appointed to Children’s Oncology Group Committee Chair

Apr. 5, 2023 - Seattle Children’s Dr. Todd Cooper will soon lead the Children’s Oncology Group Myeloid Committee.

Sarah Leary Awarded R50 to Develop Cancer Trials and Programs

Mar. 13, 2023 - The pediatric oncologist received a five-year, renewable Research Specialist Award (R50) — a new award mechanism for clinical researchers — to further her work on children’s cancer trials.

Tyler Ketterl Awarded DOD Grant to Study Germ Cell Cancers

Mar. 3, 2023 - Congratulations to Dr. Tyler Ketterl for his four-year, $1.3 million Peer Reviewed Cancer Research Program Translational Team Science Award from the U.S. Department of Defense.

Copper Intrauterine Device Affects Vaginal Bacteria and Inflammation

Jan. 30, 2023 - Researchers in the Center for Global Infectious Disease Research and colleagues found copper IUDs affect vaginal health and inflammatory response.

COVID-19 Vaccine Found Safe, Effective for Youngest Children

Feb. 16, 2023 - Research conducted with the Center for Clinical and Translational Research finds new data confirming COVID-19 vaccine safe for routine immunization for youngest children.

The Puzzling Physiology of Tuberculosis

Feb. 9, 2023 - Dr. Christoph Grundner and Center for Global Infectious Disease Research colleagues discovered how nutrients cross the outer wall of Mycobacterium tuberculosis.

Heather Gustafson Receives $4 Million MERIT Award for Pediatric Cancer Research

Feb. 9, 2023 – Dr. Heather Gustafson’s NCI MERIT funding will support inflammatory status research in pediatric cancer patients.

Maternal Immunization Boosts Vaccine-Specific T Cells in Breastmilk

Jan. 13, 2023 - Researchers in the Center for Global Infectious Disease Research and colleagues gained new insights into the immunological properties of human breastmilk.

John Aitchison and Shuyi Ma Receive $1.3 Million Award for Host-Based Antivirals

January 2023 - The Center for Global Infectious Disease Research’s Drs. John Aitchison and Shuyi Ma, and colleagues, funded by the W. M. Keck Foundation, will explore a new approach to neutralizing viruses.

Out of Mosquitos and Into Petri Dishes: New Production Platform Accelerates Malaria Vaccine

Dec. 13, 2022 - Dr. Stefan Kappe and colleagues in the Center for Global Infectious Disease Research contributed to a new malaria vaccine manufacturing platform with biotech Sanaria.

Researchers Present Findings at American Society of Hematology Annual Meeting

Dec. 6, 2022 - Seattle Children’s cancer and blood disorder research will be well represented at the American Society of Hematology (ASH) 64th annual meeting from Dec. 10 to 13 in New Orleans, Louisiana.

COVID False Positives Found in Lab Workers

Oct. 13, 2022 – Dr. Lisa Frenkel and colleagues in the Center for Global Infectious Disease Research found a common lab reagent can cause false positive COVID tests.

Anti-clotting pill may usurp current treatments in kids

Oct. 31, 2022 – Dr. Michael Portman in the Center for Integrative Brain Research and Division of Cardiology, along with an international research team, tested the safety and effectiveness of an anti-clotting pill in children.

Sleuthing the Source of a New Neurodevelopmental Disorder

Oct. 6, 2022 – Dr. Brock Grill and his lab members in the Center for Integrative Brain Research collaborated with an international research team to identify the molecular genetic cause of a new neurodevelopmental disorder.

Engineering B Cells for Future Therapies

Oct. 6, 2022 – Nature Communications published findings by Seattle Children’s Research Institute’s Drs. Richard James and David Rawlings about long-lived engineered B cells to deliver protein therapies.

New T-Cell Therapy May Treat or Prevent Type 1 Diabetes

Oct. 5, 2022 – Science Translational Medicine published new insights by Seattle Children’s Research Institute’s Dr. David Rawlings and Benaroya Research Institute’s Dr. Jane Buckner into promising T-cell therapy to treat type 1 diabetes.

Pinpointing the Origin of Deadly Brain Tumors

Sept. 21, 2022 – In two papers published in Nature, Dr. Kathleen Millen and her team are the first to identify the cells that give rise to the most aggressive forms of medulloblastoma.

One Bite Closer to a Malaria Vaccine

Sept. 1, 2022 – Science Translational Medicine published new findings by Seattle Children’s Research Institute’s Drs. Stefan Kappe and Ashley Vaughan and University of Washington’s Dr. Sean Murphy showing a genetically engineered parasite vaccine provides protection from controlled human malaria infection.

Featured Research